The kits aren’t likely to enhance American Girl’s bottom line in any significant way, yet the flood of press coverage painted the company as compassionate in a way that few such organizations are.
GSK will enlist inhaler sensor to improve clinical trials
Novartis and Amgen form neuroscience collaboration; the FDA approves a drug for people undergoing chemotherapy; a judge considers denying Pfizer’s request to toss federal lawsuit
Five things for pharma marketers to know: Tuesday, July 28
Sanofi plans immuno-oncology collaboration with Regeneron; Merck considers hard-to-treat patient populations for its experimental hepatitis-C therapy; drugmakers did not report 10% of adverse events to the FDA within required timeframe
The backlash to expensive specialty medications has forced the drug industry to partner up to prove the benefits of their medicines in the real world, according to a PwC analysis.
Five things for pharma marketers to know: Thursday, June 18
Merck settles a marketing lawsuit for $5.9 million; CVS plans to create diagnostic apps; a survey shows advertising agencies plan to keep head count steady for the rest of the year
Lilly moves to bolster its oncology pipeline
June 17, 2015
6:00 pm
Harvard’s Dana-Farber Cancer Institute and the Sarah Cannon Research Institute signed on to help the drugmaker develop cancer treatments.
Five things for pharma marketers to know: Monday, May 11